Back to results
US 2016/0103130 A1Published application
Anti-measles cancer immunotherapy
AssigneeMor Research Applications Ltd.
InventorsShmuel ARIAD, Jacob GOPAS, Daniel BENHARROCH, Irina LAZAREV
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for treating specific populations of cancer patients by immunotherapy. The methods comprise administering an immunogenic composition eliciting an immune response to measles virus to patients having measles virus-immunoreactive cancer cells.
Claims17
A method for treating cancer in a patient in need thereof, the method comprising:
- a) testing cancer cells of the patient using a measles virus immunoassay,
- b) detecting the presence of measles virus-immunoreactive cancer cells,
- c) if the patient is determined to have measles virus-immunoreactive cancer cells, administering an immunogenic composition that elicits an immune response to measles virus to the patient.
A method for treating cancer in a patient in need thereof, the method comprising:
- a) obtaining a sample of cancer cells from said patient,
- b) testing said sample for the presence of measles virus-specific mRNA,
- c) detecting the presence of measles virus-positive cancer cells,
- d) if the patient is determined to have measles virus-positive cancer cells, administering an immunogenic composition that elicits an immune response to measles virus to the patient.
1 more element
Dependencies are inferred from the claim text.